Showing posts with label simvastin. Show all posts
Showing posts with label simvastin. Show all posts
Wednesday, June 16, 2010
Osteopontin is a new target molecule for ovarian clear cell carcinoma therapy
Abstract (in research)
"Recent studies have demonstrated overexpression of osteopontin (OPN) in ovarian clear cell carcinoma.
Here, we revealed the role of OPN in invasiveness in ovarian clear cell carcinoma......Immunofluorescence analysis revealed statistically significant differences among the histological groups, and ovarian clear cell carcinoma expressed a strong OPN signal....Simvastatin significantly reduced expression of OPN and the integrins, and decreased ECM invasion. RNA interference also suppressed ECM invasion....We thus conclude that OPN regulation could have a crucial role in ovarian clear cell carcinoma therapy."
add your opinions
clear cell
,
OPN
,
osteopontin
,
simvastin
Subscribe to:
Posts
(
Atom
)